Novartis stops distribution of Zantac amidst toxin probe

Novartis ’ Sandoz unit has put the brakes on its distribution of a popular heartburn medicine as regulators investigate reports that it could be contaminated.
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news